Sanoff HK, Sargent DJ, Camp bell ME, et al: Five-year data and prog nos tic fac tor anal y sis of oxaliplatin and irinotecan com bi na tions for ad vanced colorectal can cer: N9741. J Clin Oncol 26:5721-5727, 2008
Folprecht G, Grothey A, Alberts S, et al: Neoadjuvant treat ment of unresectable colorectal liver metastases: cor re la tion be tween tu mour re sponse and re sec tion rates. Ann Oncol 16:1311-1319, 2005
Nordlinger B, Van Cutsem E, Gruenberger T, et al: Com bi na tion of sur gery and che mo ther apy and the role of tar geted agents in the treat ment of pa tients with colorectal liver metastases: rec om men da tions from an ex pert panel. Ann Oncol Jan 19, 2009 [Epub ahead of print]
Poston GJ: Sur gi cal strat e gies for colorectal liver metastases. J Clin Oncol13:125-136, 2004
Adam R, Delvart V, Pascal G, et al: Res cue sur gery for unresectable colorectal liver metastases downstaged by che mo ther apy: a model to pre dict longterm sur vival. Ann Surg 240:644-657, 2004
Alberts SR, Horvath WL, Sternfeld WC, et al: Oxaliplatin, fluorouracil, and leucovorin for pa tients with unresectable liver-only metastases from colorectal can cer: a North Cen tral Can cer Treat ment Group phase II study. J Clin Oncol 23:9243-9249, 2005 382
Poston GJ, Figueras J, Giuliante F, et al: Ur gent need for a new stag ing sys tem in ad vanced colorectal can - cer. J Clin Oncol 26:4828-4833, 2008
Choti MA: New par a digm in the treat ment of hepatic colorectal metastases: a sur geon`s per spec tive. Commun Oncol 5:9-14, 2008
Nordlinger B, Sorbye H, Glimelius B, et al: Perioperative che mo ther apy with FOLFOX4 and sur - gery ver sus sur gery alone for resectable liver metastases from colorectal can cer (EORTC In ter - group trial 40983): a ran dom ized con trolled trial. Lan - cet 371:1007-1016, 2008
Petrelli NJ: Perioperative or adjuvant ther apy for resectable colorectal hepatic metastases. J Clin Oncol 26:4862-4863, 2008
Email this article (Login required) 
